Shilpa Biocare and Orion Corporation have partnered for the exclusive distribution of Shilpa’s Recombinant Human Albumin in Europe. This deal includes milestone payments for Shilpa and expands their global biosimilar reach, leveraging Orion's established infrastructure.

• Exclusive European distribution partnership formed.
• Shilpa receives milestone payments for development.
• Addresses limitations of human-derived albumin.